Short chains of amino acid monomers which are
linked by amide bonds are termed as peptides. Peptides are different from
proteins due to difference in their sizes. Peptides contain less than 50
molecules of amino acids. Peptides bind themselves to some specific cell
surface receptors and imitate like receptor ligands. This characteristic of
peptides helps in treating various diseases as peptides act on the cell
membrane. Increasing number of cancer patients and various metabolic diseases
as well as technological advancements such as introduction of hybrid method of
synthesis of peptides, are expected to drive the peptide therapeutics market
over the forecast period. Huge market potential has been identified in peptide
therapeutics market globally and thus various pharmaceutical and biotechnology
industries are actively investing in research & development activities to
develop newer peptides to be used for various applications. Cancer has been a
major cause of death globally. According to world health organisation (WHO),
number of cancer patients is expected to increase from 12.7 million per year in
2011 to 16 million per year in 2020.
View summary of this report @ http://www.grandviewresearch.com/industry-analysis/peptide-therapeutics-market
Increase in metabolic diseases such as diabetes,
along with increase in number of cancer patients is expected to boost the
market for peptide therapeutics. Continuous R&D in peptide therapeutics has
developed various technologies and routes of administration of peptides.
However, the conventional route of administration which is parenteral route has
grabbed maximum share in terms of revenue of total market share of peptides by
route of administration in 2013. Technology market was dominated by long phase
peptide synthesis (SPSS) of total market share in 2013. Peptide therapeutics
market can be classifies on the basis of technology used, application, route of
administration and product of peptides. North America holds largest market
share while Asia Pacific region is expected to grow at a significant rate over
next six years. Key market participants for this market include Roche,
Novo-Nordisk, Bachem, Lonza, Eli Lilly, Amylin, Ipsen, Polypeptide Group,
Peptisyntha etc.
Browse
more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Key technology segments analysed in this report include solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS) and hybrid phase peptide synthesis (HPSS). SPSS technology segment dominated the overall peptide therapeutics market in terms of revenue in 2013. Due to introduction of newer technologies like HPSS, market share of SPSS is expected to reduce by 2020. HPSS is the fastest growing technological segment over the forecast period.
Free sample request of this report
- http://www.grandviewresearch.com/industry-analysis/peptide-therapeutics-market/request
No comments:
Post a Comment